| Modeling Activity: Quality Conversations With Patients About Suboptimal Management of PTSD Symptoms… | 04/09/2025 | |
| Profile and Role of Emerging Treatment Options: MOA, Safety and Efficacy, and Identifying the Patie… | 04/10/2025 | |
| Pathophysiology and Pharmacologic Rationale of Emerging Agents for the Treatment of PTSD | 04/10/2025 | |
| Limitations of Current Treatments: FDA-Approved and Off-Label Approaches | 04/02/2025 | |
| Inconsistent Outcomes: How Ignoring Guidelines Leads to Unpredictable Results | 04/09/2025 | |
| Conversations With Patients About PTSD, Screening, and Referral | 04/10/2025 | |
| Proactively Uncovering Potential Traumatic Experiences Linked to Patient Psychiatric Symptoms in Wo… | 03/26/2025 | |
| Role of PCP & Ob-Gyn With Women at Risk for PTSD: Recognition, Screening, and Referral | 04/11/2025 | |
| Prevalence and Burden of PTSD in Women: Focus on Factors That Affect Patient Presentation, Such as … | 04/12/2025 | |
| Setting the Stage: Unmet Needs in the Treatment of Women With PTSD | 04/01/2025 | |
| New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes | 04/12/2025 | |
| New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes | | |
